Intellia Therapeutics Awards Inducement Grants to New Employees

-3.41%

Intellia Therapeutics, Inc.

NTLA

13.01

-3.41%

Intellia Therapeutics Inc. has awarded inducement grants to six new employees under its 2024 Inducement Plan. The grants consist of time-based restricted stock units (RSUs) totaling 30,600 shares of common stock. One-third of the RSUs will vest annually over three years, contingent upon each employee’s continued service with the company. These grants were made under the company’s 2024 Inducement Plan, which was adopted by the board of directors in June 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9649848) on February 06, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.